Daiki Kumakura
熊倉大騎
I am a mathematical biologist and a bioinformatics researcher in the pharmaceutical industry. I received my Ph.D. in Life Science from Hokkaido University in March 2025.
I study biological dynamics using mathematical models and data analysis, with an interest in pharmacometrics and systems biology.
ORCIDGoogle ScholarLinkedInGitHub
Recent writing
Blog · 2026-11-17 · English
Elranatamab and epcoritamab studies distinguish first-dose exposure from step count and prophylaxis, with nonrandomized evidence limiting causal attribution.
Technical note · 2026-11-17 · English
Public tarlatamab CTC data distinguish normalized counts from unknown denominators and quantify conditional precision around a 25% positivity threshold.
Technical note · 2026-11-17 · English
Reanalysis of public SCLC coexpression tables compares additional RNA coverage from B7-H3 and SEZ6 across samples and cohorts, with bootstrap uncertainty and no protein or efficacy inference.
All writing · Tools and glossary